Physician profile
Tyler E Wadzinski
NPI 1124507496
$3,704.39
in general payments reported to CMS, 2019-2025
19 companies · $644 in 2025
The $644 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $170 · 2021: $173 · 2022: $110 · 2023: $1,592 · 2024: $663 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708 · Travel and Lodging: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,708.43 |
| Travel and Lodging | $1,190.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,589.53 | 2020-2024 | |
| Tarsus Pharmaceuticals, INC. | $457.24 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $271.97 | 2019-2021 | |
| Oyster Point Pharma, INC. | $266.87 | 2022-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $202.78 | 2023-2025 | Alphagan P, Lumigan, Vuity |
| Topcon Healthcare, INC. | $160.56 | 2025 | |
| Aerie Pharmaceuticals, INC. | $125.25 | 2019-2021 | |
| Alcon Vision LLC | $109.12 | 2019-2024 | Rocklatan |
| Shire North American Group INC | $79.37 | 2019 | |
| Bausch & Lomb Americas INC. | $77.99 | 2024-2025 | Vyzulta, Miebo, Infuse |
| Mallinckrodt Hospital Products INC. | $77.54 | 2024-2025 | Acthar |
| Astellas Pharma US INC | $58.51 | 2024 | Izervay |
| Carl Zeiss Meditec, INC. | $55.56 | 2019 | |
| Allergan, INC. | $51.41 | 2021-2022 | |
| Dompe US, INC. | $29.01 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $28.46 | 2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $24.00 | 2022 | |
| Rxsight INC | $23.02 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Eyevance Pharmaceuticals LLC | $16.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Wadzinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.